Related Experiment Video
Updated: Jun 2, 2026
06:15
Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
Published on: March 6, 2019
Pediatric pulmonology in a developing country: our focus
Sevgi Pekcan1, Ayşe Tana Aslan, Nural Kiper
1Department of Pediatrics, Selçuk University Faculty of Medicine, Konya, Turkey.
The Turkish Journal of Pediatrics
|May 4, 2011
Summary
This study profiled pediatric pulmonology patients in Turkey, finding significant differences between referral and definitive diagnoses. Tuberculosis and cystic fibrosis were common, highlighting the need for tailored training programs in developing countries.
Area of Science:
- Pediatric Pulmonology
- Epidemiology
- Global Health
Background:
- Developing countries like Turkey present unique pediatric pulmonology disease profiles.
- Consanguinity in developing nations increases the incidence of genetic respiratory disorders.
- Understanding local disease spectrums is crucial for effective healthcare training.
Purpose of the Study:
- To profile first-time pediatric pulmonology admissions in Turkey.
- To compare referral diagnoses with definitive diagnoses.
- To analyze treatment, ventilation, and invasive diagnostic practices.
Main Methods:
- Retrospective review of 412 pediatric pulmonology patients over six months.
- Recording referral diagnoses, definitive diagnoses, and treatment outcomes.
- Analysis of invasive and non-invasive mechanical ventilation practices.
Main Results:
- The most common diagnoses included tuberculosis (14%), cystic fibrosis (7.8%), and bronchiectasis (4.6%).
- Definitive diagnoses differed from referral diagnoses in 35.2% of patients.
- Genetic diseases and infectious conditions like tuberculosis and hydatid cysts are prevalent.
Conclusions:
- Pediatric pulmonology patient profiles in developing countries necessitate tailored diagnostic and treatment approaches.
- Discrepancies between referral and definitive diagnoses underscore the need for specialized training.
- Healthcare educational programs should adapt to unique national disease spectra.
Related Concept Videos
01:29Chronic Obstructive Pulmonary Disease-V: Management
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:17Other Pulmonary Disorders
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:28Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...